New Disease Compounds Research Library Launched by the Medical Research Council

The Medical Research Council (MRC) has teamed up with six pharmaceutical companies to create a disease compounds library for academic researchers around the world. The library is the latest product of the MRC’s Industry Asset Sharing Initiative, which comprises of 47 deprioritised compounds contributed by AstraZeneca, GlaxoSmithKline, Janssen, Pfizer, Takeda and UCB. Both pre-clinical and

Continue Reading